SCHEMBL6709172

SCHEMBL6709172

O=C(Nc1ccc(Cl)cc1-c1nnn[nH]1)c1noc2ccc(Br)cc12

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 5/20 0.42
GPR35 Q9HC97 4/20 0.40
MEN1 O00255 5/20 0.36
KMT2A Q03164 5/20 0.36
MAPT P10636 3/20 0.36
HPGD P15428 3/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
RAB9A P51151 2/20 0.36
GRM5 P41594 1/20 0.36
LMNA P02545 2/20 0.34
ALDH1A1 P00352 1/20 0.34
POLB P06746 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
GRIK1 P39086 1/20 0.34
ACLY P53396 1/20 0.34
NPC1 O15118 1/20 0.34
HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6710349 0.93 HIF1A (0.38) HIF1AGPR35MEN1KMT2AMAPT
SCHEMBL6711782 0.91 HIF1A (0.41) HIF1AGPR35MEN1KMT2AMAPT
SCHEMBL6708718 0.89 HIF1A (0.42) HIF1AMEN1KMT2AMAPTHPGD
SCHEMBL6710375 0.87 HIF1A (0.57) HIF1A
SCHEMBL6708056 0.87 HIF1A (0.46) HIF1AMEN1KMT2AGRM5ALDH1A1
SCHEMBL6710266 0.87 HIF1A (0.44) HIF1AMEN1KMT2ASMN1; SMN2RAB9A
SCHEMBL6707747 0.87 HIF1A (0.35) HIF1AGPR35MEN1KMT2AMAPT
SCHEMBL6709290 0.86 GPR35 (0.34) HIF1AGPR35MEN1KMT2AMAPT
SCHEMBL6707935 0.86 HIF1A (0.45) HIF1AMEN1KMT2AMAPTHPGD
SCHEMBL6709217 0.86 HIF1A (0.38) HIF1AGPR35MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 HIF1A 296/4885GPR35 2928/4885MEN1 4100/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.